Related Experiment Video
Updated: Jul 3, 2026

Anesthesia and Intubation of Preadolescent Mouse Pups for Cardiothoracic Surgery
Published on: June 2, 2022
Dosing ketamine for pediatric procedural sedation in the emergency department
Daniel Dallimore1, David W Herd, Tim Short
1Department of Anaesthesia, Auckland City Hospital, New Zealand.
Insights
Optimizing ketamine for pediatric procedural sedation requires age-specific dosing. Lower doses with infusions or top-ups provide better sedation and faster recovery in children.
Area of Science:
- Pediatric Anesthesiology
- Pharmacokinetics and Pharmacodynamics
- Procedural Sedation
Background:
- Intravenous ketamine is used for pediatric procedural sedation.
- Optimal dosing regimens for children are not well-established.
- Age-dependent responses to ketamine require investigation.
Purpose of the Study:
- To describe intravenous ketamine dosing regimens for children requiring brief procedural sedation.
- To simulate pharmacokinetic and pharmacodynamic profiles for various pediatric age groups.
- To evaluate single-dose, repeat-dosing, and infusion strategies.
Main Methods:
- Simulated time-concentration and sedation profiles in children aged 2, 6, and 12 years.
- Utilized published pediatric pharmacokinetic and pharmacodynamic parameters.
- Investigated regimens to achieve a specific sedation level for 15 minutes.
Main Results:
- Single bolus doses varied by age, with higher doses for younger children.
- A single large dose resulted in slow recovery (70 minutes to sedation level 4).
- A smaller initial bolus with a top-up or infusion led to earlier recovery (20 minutes).
Conclusions:
- Ketamine dosage increases with decreasing age in children.
- Large single doses are linked to deep sedation and delayed recovery.
- Tailoring doses to individual needs and pain type (intermittent vs. continuous) is crucial.
Objective:
To describe intravenous ketamine dosing regimens for children requiring brief procedural sedation.
Methods:
Time-concentration and sedation profiles were simulated in children (2, 6, and 12 years old) using published pediatric pharmacokinetic and pharmacodynamic parameter estimates. Single-dose, repeat-dosing, and infusion regimens to achieve sedation level of less than 2 (arouses slowly to consciousness, with sustained painful stimulus) for 15 minutes were investigated.
Results:
A single bolus dose of 1.5 and 1.75, 2, and 2.125 mg/kg (for adult and 12-, 6-, and 2-year-olds, respectively) was required to achieve the desired sedation. Anticipated recovery would be slow, and a sedation level of 4 (drowsy, eyes open or closed but easily arouses to consciousness with verbal stimulus) was reached only after 70 minutes. The use of a smaller initial bolus with a subsequent half-dose "top-up" at 8 minutes achieves the same sedation level but with earlier recovery. A smaller initial dose of 0.25 and 0.275, 0.3, and 0.35 mg/kg followed by an infusion 2.5 and 2.75, 3, and 3.5 mg/kg per hour (for adult and 12-, 6-, and 2-year-olds, respectively) for 15 minutes gives a more even sedation level and rapid recovery (20 minutes to sedation level 4).
Conclusions:
Dosing increases with decreasing age. A large single dose is associated with deep sedation, possible adverse effects, and delayed recovery. Between-subjects variability is large, and dose should be tailored to clinical monitoring and requirement. Intermittent pain insult is better suited to a top-up technique, whereas continuous pain is better suited to an infusion technique.
Related Concept Videos
Parenteral Anesthetics: Overview
Drug Dosing: Infants and Children
Pharmacokinetics in Pediatric Patients: Drug Excretion
Depolarizing Blockers: Pharmocokinetics
Stages of General Anesthesia
Drug Delivery: Enteral Route
Drugs in...
